US Oncology Director of Finance Salaries in Houston | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Director of Finance Salaries in Houston

The average US Oncology Director of Finance in Houston earns an estimated $167,377 annually. US Oncology's Director of Finance compensation is $5,361 more than the US average for a Director of Finance.

In Houston, The Finance Department at US Oncology earns $35,238 more on average than the Admin Department.

Last updated 7 months ago.

$30k
$74k
$117k
$159k
$350k
$600k
$167,377
Average Compensation
$167,377
avg. base

Director of Finance Salaries at US Oncology

In Houston, Directors of Finance earn $46,149 more than Accounting Managers.

Accounting Manager
$121k*
Senior Accountant
$102k*
Financial Analyst
$101k*
Business Analyst
$87k*
Accountant
$71k*
* estimated salary

Compensation at US Oncology by Department

In Houston, The Finance Department averages $35,238 more than the Admin Department, and $19,647 less than the IT Department

IT
$105,067 Avg. total comp.
+$20k
Finance
$85,420 Avg. total comp.
Admin
$50,182 Avg. total comp.
-$35k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to US Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to US Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at US Oncology Rate Their Compensation

The majority of Directors of Finance at US Oncology believe they're compensated fairly. 50% of Directors of Finance at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company